Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108651-108700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05250154
Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study
N/AActive, not recruiting
2,438 participants
Started: Aug 27, 2018 · Completed: May 1, 2040
1 condition3 sponsors1 location
NCT03457948
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
PHASE2Active, not recruiting
32 participants
Started: Aug 27, 2018 · Completed: May 31, 2026
2 conditions3 sponsors1 location
NCT03784066
Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
PHASE1/PHASE2Active, not recruiting
21 participants
Started: Aug 27, 2018 · Completed: Mar 24, 2026
1 condition4 sponsors1 location
NCT03670368
Interpersonal Relationships Intervention and Cardiovascular Health
NARecruiting
500 participants
Started: Aug 27, 2018 · Completed: May 31, 2026
1 condition5 sponsors1 location
NCT03600441
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
PHASE2Active, not recruiting
139 participants
Started: Aug 27, 2018 · Completed: Dec 31, 2029
1 condition1 sponsor15 locations
NCT04201704
Effect of Giving Reduced Fluid in Children After Trauma
NARecruiting
250 participants
Started: Aug 27, 2018 · Completed: Sep 30, 2026
5 conditions5 sponsors4 locations
NCT03600883
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
PHASE1/PHASE2Active, not recruiting
713 participants
Started: Aug 27, 2018 · Completed: Jan 31, 2026
1 condition1 sponsor133 locations
NCT03531255
Pegcetacoplan Long Term Safety and Efficacy Extension Study
PHASE3Active, not recruiting
160 participants
Started: Aug 27, 2018 · Completed: Jun 30, 2025
1 condition1 sponsor62 locations
NCT03838107
Markers of Trajectory in Pediatric CRPS
N/ARecruiting
126 participants
Started: Aug 27, 2018 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT03673007
Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1
NAActive, not recruiting
4,633 participants
Started: Aug 26, 2018 · Completed: Dec 31, 2028
1 condition2 sponsors9 locations
NCT04371900
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
NARecruiting
4,700 participants
Started: Aug 26, 2018 · Completed: Dec 31, 2049
1 condition3 sponsors9 locations
NCT03687593
Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts
N/AActive, not recruiting
126 participants
Started: Aug 26, 2018 · Completed: Apr 1, 2028
1 condition1 sponsor4 locations
NCT06560606
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
N/ARecruiting
4,100 participants
Started: Aug 24, 2018 · Completed: Mar 30, 2027
1 condition9 sponsors19 locations
NCT02558699
Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation
NARecruiting
110 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03168802
MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain
NARecruiting
100 participants
Started: Aug 24, 2018 · Completed: Nov 25, 2025
2 conditions1 sponsor1 location
NCT03698552
ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
PHASE1/PHASE2Recruiting
57 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2025
5 conditions3 sponsors2 locations
NCT03535350
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PHASE1Active, not recruiting
36 participants
Started: Aug 24, 2018 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03391973
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
PHASE2Active, not recruiting
26 participants
Started: Aug 24, 2018 · Completed: Dec 30, 2025
1 condition2 sponsors3 locations
NCT03347227
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
NARecruiting
502 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors15 locations
NCT03609060
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
PHASE2Active, not recruiting
120 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor25 locations
NCT03556085
Venous Sinus Stenting With the River Stent in IIH
NAActive, not recruiting
39 participants
Started: Aug 24, 2018 · Completed: Nov 1, 2026
1 condition1 sponsor6 locations
NCT03603912
Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
PHASE4Active, not recruiting
175 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT03581942
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Aug 23, 2018 · Completed: Jul 31, 2026
1 condition1 sponsor7 locations
NCT03485547
Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
PHASE1Active, not recruiting
5 participants
Started: Aug 23, 2018 · Completed: Feb 17, 2026
1 condition2 sponsors2 locations
NCT03638297
PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer
PHASE2Recruiting
29 participants
Started: Aug 23, 2018 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT03527472
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
PHASE2Active, not recruiting
111 participants
Started: Aug 23, 2018 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT03533517
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
NAActive, not recruiting
22 participants
Started: Aug 23, 2018 · Completed: Feb 28, 2026
2 conditions1 sponsor18 locations
NCT03606161
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
NAActive, not recruiting
32 participants
Started: Aug 23, 2018 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT03880383
BRIGHT Coaching Program for Families
NAActive, not recruiting
306 participants
Started: Aug 23, 2018 · Completed: Mar 31, 2025
7 conditions3 sponsors4 locations
NCT03642639
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
NAActive, not recruiting
850 participants
Started: Aug 23, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor3 locations
NCT03374657
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Aug 22, 2018 · Completed: May 11, 2026
1 condition1 sponsor1 location
NCT03633799
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
PHASE3Active, not recruiting
1,620 participants
Started: Aug 22, 2018 · Completed: Sep 22, 2027
1 condition2 sponsors41 locations
NCT03667170
KN035 for dMMR/MSI-H Advanced Solid Tumors
PHASE2Recruiting
200 participants
Started: Aug 22, 2018 · Completed: Dec 15, 2026
1 condition1 sponsor1 location
NCT03587740
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
PHASE2Active, not recruiting
82 participants
Started: Aug 22, 2018 · Completed: Aug 30, 2029
1 condition3 sponsors14 locations
NCT03601923
Niraparib in Patients With Pancreatic Cancer
PHASE2Active, not recruiting
32 participants
Started: Aug 22, 2018 · Completed: Feb 28, 2026
1 condition2 sponsors3 locations
NCT03655353
A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer
NARecruiting
160 participants
Started: Aug 22, 2018 · Completed: Nov 1, 2025
1 condition5 sponsors1 location
NCT03839706
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
NAActive, not recruiting
20 participants
Started: Aug 22, 2018 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT03320759
Enhancing Recovery in Non-Traumatic Spinal Cord Injury
NARecruiting
40 participants
Started: Aug 21, 2018 · Completed: Jul 1, 2026
4 conditions1 sponsor1 location
NCT03643510
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
PHASE2Active, not recruiting
28 participants
Started: Aug 21, 2018 · Completed: Aug 31, 2026
1 condition2 sponsors7 locations
NCT03647358
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
PHASE1Recruiting
60 participants
Started: Aug 21, 2018 · Completed: Aug 31, 2026
2 conditions1 sponsor2 locations
NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
PHASE3Recruiting
3,500 participants
Started: Aug 21, 2018 · Completed: Aug 4, 2043
2 conditions1 sponsor684 locations
NCT03635229
Risk Factor of POD and POCD After Cardiac Surgery
N/AActive, not recruiting
360 participants
Started: Aug 21, 2018 · Completed: Dec 31, 2023
2 conditions1 sponsor1 location
NCT03400826
Effects of Simvastatin on Uterine Leiomyoma Size
PHASE2Recruiting
60 participants
Started: Aug 20, 2018 · Completed: Jul 31, 2026
5 conditions3 sponsors1 location
NCT03560752
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant
PHASE1Active, not recruiting
34 participants
Started: Aug 20, 2018 · Completed: Aug 27, 2025
14 conditions2 sponsors1 location
NCT06308822
Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)
PHASE2Active, not recruiting
35 participants
Started: Aug 20, 2018 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT03583710
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
PHASE3Recruiting
240 participants
Started: Aug 20, 2018 · Completed: Jan 1, 2029
3 conditions6 sponsors23 locations
NCT03649490
Advanced Materials Science in XLIF Study
N/AEnrolling by invitation
300 participants
Started: Aug 19, 2018 · Completed: Dec 1, 2025
2 conditions1 sponsor15 locations
NCT03714282
Noninvasive Spinal Stimulation in Stroke
NARecruiting
90 participants
Started: Aug 17, 2018 · Completed: Dec 31, 2022
1 condition2 sponsors1 location
NCT03678441
Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery
NAActive, not recruiting
100 participants
Started: Aug 17, 2018 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05875116
Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
NARecruiting
119 participants
Started: Aug 17, 2018 · Completed: Aug 21, 2024
1 condition1 sponsor1 location